Skip to main content
. 2019 Dec 16;4(6):e001921. doi: 10.1136/bmjgh-2019-001921

Table 1.

Baseline characteristics of participants* in intervention and control arms

Baseline 1
(before follow-up began)
Baseline 2
(before training began)
Control Intervention Control Intervention
N % N % N % N %
Participants with asthma 2206 100.0 2017 100.0 2161 100.0 1918 100.0
Sex (male) 614 27.8 515 25.5 591 27.4 485 25.3
Inhaled corticosteroid ever 820 37.2 814 40.4 752 34.8 703 36.7
Short acting beta2-agonist ever 761 34.5 755 37.4 705 32.6 652 34.0
Long acting beta2-agonist+ICS ever 302 13.7 320 15.9 269 12.5 275 14.3
Any of the above ever prescribed 995 45.1 1005 49.8 911 42.2 883 46.0
†Asthma score=0 1782 80.8 1502 74.5 1748 80.9 1483 77.3
Asthma score=1 366 16.6 428 21.2 348 16.1 369 19.2
Asthma score=2 58 2.6 87 4.3 65 3.0 66 3.4
Asthma score: start or change treatment‡ 339 15.4 387 19.2 319 14.8 333 17.4
Asthma score: spirometry‡ 143 6.5 215 10.7 159 7.4 168 8.8
COPD ever diagnosed 442 20.0 468 20.2 437 20.2 453 23.6
Mean SD Mean SD Mean SD Mean SD
Clinic level asthma score 0.214 0.107 0.293 0.124 0.206 0.110 0.287 0.119
Age (years) 48.3 18.0 49.1 17.9 48.0 18.8 48.7 17.8
N % N % N % N %
Participants with COPD 1042 100.0 1190 100.0 1025 100.0 1169 100.0
Sex (male) 450 43.2 493 40.7 445 43.4 471 40.3
Inhaled corticosteroid ever 343 32.9 390 32.2 306 29.9 342 29.5
Short acting beta2-agonist ever 302 29.0 341 32.2 274 26.7 299 25.6
Long acting beta2-agonist+ICS ever 213 20.9 264 28.1 188 18.3 223 19.1
Any of the above ever prescribed 463 44.4 549 45.3 417 40.7 482 41.2
COPD score=0† 88.1 84.6 943 77.8 849 82.8 948 81.1
COPD score=1 130 12.5 220 18.2 145 14.2 175 15.0
COPD score=2 31 3.0 48 4.0 31 3.0 46 4.9
COPD score: start or change treatment‡ 93 8.9 137 11.3 95 9.3 125 10.7
COPD score: spirometry‡ 99 9.5 181 14.9 112 10.9 142 12.2
Asthma ever diagnosed 442 42.4 468 38.6 437 42.6 453 38.8
Mean SD Mean SD Mean SD Mean SD
Age (mean) 62.2 13.4 61.9 13.4 61.7 13.1 61.1 13.6
N % N % N % N %
Participants with asthma or COPD 2806 100.0 2761 100.0 2749 100.0 2632 100.0
Sex (male) 885 31.5 840 30.4 857 31.2 794 30.1
Cardiovascular disease newly diagnosed§ 91 3.2 124 4.5 1147 4.2 130 4.9
Cardiovascular risk assessed¶ 1785 63.6 1751 63.4 1829 66.5 1791 68.0
Diabetes newly diagnosed 91 3.2 113 4.1 86 3.1 97 3.7
Nicotine or buproprion or nortriptyline prescribed 76 2.7 102 3.7 87 3.2 90 3.4
Depression newly diagnosed 69 2.5 107 3.9 65 2.4 80 3.0
Antidepressant treatment started 87 3.1 118 4.3 105 3.8 117 4.4
Mean SD Mean SD Mean SD Mean SD
Clinic level COPD score 0.186 0.078 0.269 0.173 0.202 0.834 0.225 0.102
Age (years) 51.3 18.0 52.7 17.8 51.1 17.8 52.2 17.6
Clinic level diagnosis and hospital admission ratios**
New asthma and COPD diagnoses 10.3 4.2 10.9 4.7 11.2 4.3 9.5 3.1
New asthma diagnoses 7.3 3.2 7.4 3.9 7.8 3.7 6.2 2.7
New COPD diagnoses 3.0 1.9 3.6 2.2 3.4 1.4 3.3 1.4
Hospital admissions for asthma or COPD 1.3 1.1 0.80 0.61 0.57 0.65 0.59 0.46

*Excludes participants newly diagnosed with asthma or COPD during follow-up.

†Primary outcomes.

‡Components added to create primary outcomes.

§ICD-10 I00–I99.

¶Blood pressure, cholesterol, glucose and/or ECG recorded.

**No of new diagnoses or hospital admissions: 1000 adults visiting clinic during the year.

COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroid.